Health Ministry Halts Use of Specific Similac Batch in Hospitals
Translated & summarized from NEWSru Israel by baba
Israel's Ministry of Health has suspended the use of a specific batch of Similac infant formula in hospitals nationwide due to a single complaint. The affected batch is exclusively for hospital use, and the manufacturer is providing an alternative.
The story in 5 lines · by baba
- Health Ministry halts use of specific Similac batch in hospitals.
- Decision follows a single complaint about batch 89203N201.
- The batch is exclusively for hospital distribution, not retail.
- No health issues have been reported; investigation is underway.
- Manufacturer Abbott is supplying an alternative batch.
Israel's Ministry of Health has ordered a temporary halt to the use of a specific batch of Similac infant formula intended solely for hospital distribution. The decision follows a single complaint received late yesterday concerning batch number 89203N201, which is clearly marked on the bottom of the bottle. This batch is exclusively supplied to hospitals and is not available in retail stores.
As a precautionary measure, the ministry has suspended the use of this particular batch pending the completion of an investigation. At this stage, only one complaint has been reported, and there have been no reports of any health issues arising from its use. The manufacturer, Abbott, is reportedly arranging to supply hospitals with an alternative batch of the product.
The ministry emphasized that this directive applies exclusively to batch 89203N201 and that there are no restrictions on the use of any other Similac batches.
